Efficacy and safety of meropenem as an empirical treatment for febrile neutropenia in children with cancer

Journal of the Medical Association of Thailand

Volumn 86, Issue SUPPL. 2, 2003, Pages

  Pancharoen, Chitsanu ^a   Buranachonapa, Jiranun ^a   Nuchprayoon, Issarang ^a   Seksarn, Panya ^a   Mekmullica, Jutarat ^a   Trongjit, Duangjai ^a   Vanichsetakul, Preeda ^a   Thisyakorn, Usa ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Children; Febrile Neutopenia; Meropenem

Indexed keywords

MEROPENEM;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE BACTERIUM; HISTIOCYTOSIS; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; RASH; RETINOBLASTOMA; TREATMENT FAILURE; TREATMENT OUTCOME; URINE CULTURE; YOLK SAC TUMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; MALE; NEOPLASMS; NEUTROPENIA; THIENAMYCINS;

EID: 0041429617     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Glauser M. Empiric therapy of bacterial infections in patients with severe neutropenia. Diagn Microbiol Infect Dis 1998; 31: 467-72.
2. Wiseman LR, Wagstaff AJ, Bragden RN, Bryson HM. Meropenem: A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1995; 50: 73-101.
3. Vandercam B, Gerain J, Humblet Y, et al. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients. Ann Hematol 2000; 79: 152-7.
4. Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial. J Clin Oncol 2000; 18: 3690-8.
5. Bradley JS, Faulkner KL, Klugman KP. Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients. Pediatr Infect Dis J 1996; 15: 749-57.
6. Blumer JL. Carbapenems in paediatrics. Scand J Infect Dis 1995; 96 (Suppl): 38-44.
7. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323-32.
8. Cometta A, Viscoli C, Castagnola E, et al. Empiric treatment of fever in neutropenic children: The role of the carbapenems. Pediatr Infect Dis J 1996; 15: 744-8.
9. Schuler D and the Meropenem Paediatric Study Group. Safety and efficacy of meropenem in hospitalized children: Randomized comparison with cefotaxime, alone and combined with metronidazole or amikacin. J Antimicrob Chemother 1995; 36 (Suppl A): 99-108.
10. Fleischhack G, Hartmann C, Simon A, et al. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chem 3001; 47: 841-53.
11. Punpanich W, Sawadichai K, Pratuangtham S, Hathirat P. Trends in bacterial infection in febrile neutropenic children; Ramathibodi Hospital. Thai J Pediatr 1999; 38: 9-16.
12. Anunnatsiri S, Chansung K, Chetchotisakd P, Sirijerachai C. Febrile neutropenia: A retrospective study in Srinagarind Hospital. J Infect Dis Antimicrob Agents 1998; 15: 115-22.
13. Pancharoen C, Thisyakorn U. Nontyphoidal nonparatyphoidal salmonellosis in Thai children. Typhoid Fever and other Salmonellosis 2001: 77-81.